Products for Research Use Only

RIPK2-IN-6

CAT: 0804-HY-168567Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-168567Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RIPK2-IN-6 (Compound 15a) is an inhibitor for RIPK, that inhibits the phosphorylation of RIPK2, and thus inhibits the NF-κB and MAPK signaling pathways. RIPK2-IN-6 exhibits anti-inflammatory and anti-fibrotic activities in Dextran sodium sulfate -induced mice colitis models[1].
CAS Number
2242432-02-4
UNSPSC
12352005
Target
NF-κB; p38 MAPK; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis; MAPK/ERK Pathway; NF-κB
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ripk2-in-6.html
Smiles
O=C1CC(C)(C)C2=CC=C(C(OC=C3C)=C3C4=O)C5=C4N(CC6=CC=CC=C6)C1=C25
Molecular Formula
C26H21NO3
Molecular Weight
395.45
References & Citations
[1]Hu CH, et al., A derivative of tanshinone IIA and salviadione, 15a, inhibits inflammation and alleviates DSS-induced colitis in mice by direct binding and inhibition of RIPK2. Acta Pharmacol Sin. 2024 Oct 23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported